uridine triphosphate has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, VS; Cardoso, TC; Monteiro, MMLV; Rocha, MA; Savio, LEB; Silva, CLM | 1 |
| Carraway, RE; Mitra, SP | 1 |
2 other study(ies) available for uridine triphosphate and Cancer of Prostate
| Article | Year |
|---|---|
The blockage of downstream P2Y
Topics: Adenosine Triphosphate; Atorvastatin; Cell Adhesion; Endothelial Cells; Humans; Male; Prostatic Neoplasms; Tumor Microenvironment; Uridine Triphosphate | 2022 |
Neurotensin enhances agonist-induced cAMP accumulation in PC3 cells via Ca2+ -dependent adenylyl cyclase(s).
Topics: Adenylyl Cyclases; Calcium; Cholera Toxin; Colforsin; Cyclic AMP; Dinoprostone; Drug Synergism; Egtazic Acid; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Humans; Ionomycin; Isoproterenol; Male; Neurotensin; Prostatic Neoplasms; Thapsigargin; Tumor Cells, Cultured; Uridine Triphosphate | 1998 |